FoundationOne CDx

**Semantic type:** Laboratory Procedure

**Definition:** A proprietary tissue-based broad companion diagnostic (CDx) test that is clinically and analytically validated for all solid tumors. Test results include microsatellite instability (MSI), tumor mutational burden (TMB), and homologous recombination deficiency (HRD) signature for all solid tumors to help inform immunotherapy decisions.